Quarterly Results

  • Company Name :
Concord Biotech Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543960
  • NSE Symbol:
  • CONCORDBIO
  • P/E(TTM):
  • 45.75
  • ISIN Demat:
  • INE338H01029
  • Div & Yield%:
  • 0.62
  • EPS(TTM):
  • 30.73
  • Book Value(₹):
  • 174.47
  • Market Cap(₹Cr.):
  • 14,708.52
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 247.06 203.99 429.88
Excise Duty 0.00 0.00 0.00
Net Sales 247.06 203.99 429.88
Other Operating Income 0.00 0.00 0.00
Other Income 13.43 13.68 9.38
Total Income 260.49 217.67 439.27
Total Expenditure 156.52 142.59 239.46
PBIDT 103.97 75.07 199.81
Interest 0.06 0.06 0.10
PBDT 103.91 75.02 199.71
Depreciation 18.39 17.78 14.62
Tax 22.00 14.08 41.82
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.63 0.60 1.34
Reported Profit After Tax 62.90 42.57 141.94
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 62.90 42.57 141.94
EPS (Unit Curr.) 6.01 4.07 13.57
EPS (Adj) (Unit Curr.) 6.01 4.07 13.57
Calculated EPS (Unit Curr.) 6.01 4.07 13.57
Calculated EPS (Adj) (Unit Curr.) 6.01 4.07 13.57
Calculated EPS (Ann.) (Unit Curr.) 24.05 16.27 54.27
Calculated EPS (Adj) (Ann.) (Unit Curr.) 24.05 16.27 54.27
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.46 10.46 10.46
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 42.08 36.80 46.48
PBDTM(%) 42.06 36.78 46.46
PATM(%) 25.46 20.87 33.02